Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Alison R. Sehgal"'
Autor:
Antonio Cuneo, Anthony R. Mato, Gian Matteo Rigolin, Alfonso Piciocchi, Massimo Gentile, Luca Laurenti, John N. Allan, John M. Pagel, Danielle M. Brander, Brian T. Hill, Allison Winter, Nicole Lamanna, Constantine S. Tam, Ryan Jacobs, Frederick Lansigan, Paul M. Barr, Mazyar Shadman, Alan P. Skarbnik, Jeffrey J. Pu, Alison R. Sehgal, Stephen J. Schuster, Nirav N. Shah, Chaitra S. Ujjani, Lindsey Roeker, Ester Maria Orlandi, Atto Billio, Livio Trentin, Martin Spacek, Monia Marchetti, Alessandra Tedeschi, Fiorella Ilariucci, Gianluca Gaidano, Michael Doubek, Lucia Farina, Stefano Molica, Francesco Di Raimondo, Marta Coscia, Francesca Romana Mauro, Javier de la Serna, Angeles Medina Perez, Isacco Ferrarini, Giuseppe Cimino, Maurizio Cavallari, Rosalba Cucci, Marco Vignetti, Robin Foà, Paolo Ghia, the GIMEMA, European Research Initiative (ERIC) on CLL, US study group
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8468-8479 (2020)
Abstract Limited information is available on the efficacy of front‐line bendamustine and rituximab (BR) in chronic lymphocytic leukemia (CLL) with reduced renal function or coexisting conditions. We therefore analyzed a cohort of real‐world patie
Externí odkaz:
https://doaj.org/article/51d4f3af2edb4e18930e0b7ba14d8eff
Autor:
Anthony R. Mato, Meghan Thompson, John N. Allan, Danielle M. Brander, John M. Pagel, Chaitra S. Ujjani, Brian T. Hill, Nicole Lamanna, Frederick Lansigan, Ryan Jacobs, Mazyar Shadman, Alan P. Skarbnik, Jeffrey J. Pu, Paul M. Barr, Alison R. Sehgal, Bruce D. Cheson, Clive S. Zent, Hande H. Tuncer, Stephen J. Schuster, Peter V. Pickens, Nirav N. Shah, Andre Goy, Allison M. Winter, Christine Garcia, Kaitlin Kennard, Krista Isaac, Colleen Dorsey, Lisa M. Gashonia, Arun K. Singavi, Lindsey E. Roeker, Andrew Zelenetz, Annalynn Williams, Christina Howlett, Hanna Weissbrot, Naveed Ali, Sirin Khajavian, Andrea Sitlinger, Eve Tranchito, Joanna Rhodes, Joshua Felsenfeld, Neil Bailey, Bhavisha Patel, Timothy F. Burns, Melissa Yacur, Mansi Malhotra, Jakub Svoboda, Richard R. Furman, Chadi Nabhan
Publikováno v:
Haematologica, Vol 103, Iss 9 (2018)
Venetoclax is a BCL2 inhibitor approved for 17p-deleted relapsed/refractory chronic lymphocytic leukemia with activity following kinase inhibitors. We conducted a multicenter retrospective cohort analysis of patients with chronic lymphocytic leukemia
Externí odkaz:
https://doaj.org/article/cf0cc2d2d3144e71a74d686f011301aa
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Supplemental Figure S1. Patient flow diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32c3aef36f1dc12f778f992b823a999e
https://doi.org/10.1158/1078-0432.22460405
https://doi.org/10.1158/1078-0432.22460405
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Purpose: DNA methyltransferase 3A (DNMT3A) is one of the commonly mutated genes in acute myelogenous leukemia (AML). Reports on the prognostic significance of DNMT3A mutations have been inconsistent, and most of the data are available only for patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::413618039935bc8d0919d30ca836ebda
https://doi.org/10.1158/1078-0432.c.6524483
https://doi.org/10.1158/1078-0432.c.6524483
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Supplemental Table S1. Frequency of DNMT3A mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482d913e57c02bf12b6c4e7d8baa3a0e
https://doi.org/10.1158/1078-0432.22460399.v1
https://doi.org/10.1158/1078-0432.22460399.v1
Autor:
Martin Carroll, Alison W. Loren, Selina Luger, Jennifer D. Morrissette, Robert Daber, Jing-Mei Hsu, Jianhua Zhao, Phyllis A. Gimotty, Alison R. Sehgal
Supplementary Table and Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e28d3a0867eee88643e9a7d45580718e
https://doi.org/10.1158/1078-0432.22460393.v1
https://doi.org/10.1158/1078-0432.22460393.v1
Autor:
Caron A, Jacobson, Julio C, Chavez, Alison R, Sehgal, Basem M, William, Javier, Munoz, Gilles, Salles, Pashna N, Munshi, Carla, Casulo, David G, Maloney, Sven, de Vos, Ran, Reshef, Lori A, Leslie, Ibrahim, Yakoub-Agha, Olalekan O, Oluwole, Henry Chi Hang, Fung, Joseph, Rosenblatt, John M, Rossi, Lovely, Goyal, Vicki, Plaks, Yin, Yang, Remus, Vezan, Mauro P, Avanzi, Sattva S, Neelapu
Publikováno v:
The Lancet Oncology. 23:91-103
Most patients with advanced-stage indolent non-Hodgkin lymphoma have multiple relapses. We assessed axicabtagene ciloleucel autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory indolent non-Hodgkin lymphoma.ZU
Autor:
Nilanjan Ghosh, Alison R. Sehgal, Fei Fei Liu, Ana Kostic, Alessandro Crotta, Lily Peng, Marc De Benedetti, Leo I. Gordon
Publikováno v:
Blood. 140:10430-10431
Autor:
Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew L. Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph Rosenblatt, Jiali Yan, Qinghua Song, Weixin Peng, Christine Lui, Jacob Wulf, Rhine R. Shen, Soumya Poddar, Harry Miao, Sara Beygi, Caron A. Jacobson
Publikováno v:
Transplantation and Cellular Therapy. 29:S374
Autor:
Abhinav Deol, Amanda F. Cashen, N. Nora Bennani, Khoan Vu, Michael D. Jain, David B. Miklos, Sattva S. Neelapu, Brian T. Hill, Jason R. Westin, Julie M. Vose, Alison R. Sehgal, Julio C. Chavez, Aaron P. Rapoport, Lazaros J. Lekakis, Andre Goy, Patrick M. Reagan, Javier Munoz, Joseph P. McGuirk, Loretta J. Nastoupil, Lei Feng, Olalekan O. Oluwole, Saurabh Dahiya, Jay Y. Spiegel, Frederick L. Locke, Charalambos Andreadis, Yi Lin, Matthew A. Lunning, Armin Ghobadi
Publikováno v:
J Clin Oncol
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 27
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 27
PURPOSE Axicabtagene ciloleucel (axi-cel) is an autologous CD19-directed chimeric antigen receptor (CAR) T-cell therapy approved for relapsed/refractory large B-cell lymphoma (LBCL) on the basis of the single-arm phase II ZUMA-1 trial, which showed b